125 related articles for article (PubMed ID: 38035868)
1. Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients.
Rydzinski M; Bijok M; Michalski W; Kowalczyk A; Gruszczynska E; Zolciak-Siwinska A
Gynecol Oncol; 2024 Jan; 180():6-13. PubMed ID: 38035868
[TBL] [Abstract][Full Text] [Related]
2. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
3. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gebhardt B; Gill B; Glaser S; Kim H; Houser C; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):302-308. PubMed ID: 28923412
[TBL] [Abstract][Full Text] [Related]
4. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
5. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
7. Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.
Ohkubo Y; Kato S; Kiyohara H; Tsuruoka I; Tamaki T; Noda SE; Ohno T; Nakano T
J Radiat Res; 2011; 52(5):666-73. PubMed ID: 21857147
[TBL] [Abstract][Full Text] [Related]
8. Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy.
Acharya S; Esthappan J; Badiyan S; DeWees TA; Tanderup K; Schwarz JK; Grigsby PW
Radiother Oncol; 2016 Jan; 118(1):167-72. PubMed ID: 26743834
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
11. Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients.
Espenel S; Kissel M; Garcia MA; Schernberg A; Gouy S; Bockel S; Limkin E; Fabiano E; Meillan N; Magné N; Leary A; Pautier P; Morice P; Fumagalli I; Haie-Meder C; Chargari C
Gynecol Oncol; 2020 Aug; 158(2):323-330. PubMed ID: 32475773
[TBL] [Abstract][Full Text] [Related]
12. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
13. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer.
Jones R; Chen Q; Best R; Libby B; Crandley EF; Showalter TN
Radiat Oncol; 2014 Jul; 9():164. PubMed ID: 25059785
[TBL] [Abstract][Full Text] [Related]
15. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma.
Gill BS; Kim H; Houser C; Olsen A; Kelley J; Edwards RP; Comerci J; Sukumvanich P; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2014; 13(6):542-7. PubMed ID: 25127122
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer.
Alban GM; Buscariollo DL; Cheng T; Pretz J; Krechmer B; Buzurovic I; Singer L; King M; Lee L
Pract Radiat Oncol; 2020; 10(2):95-103. PubMed ID: 31783169
[TBL] [Abstract][Full Text] [Related]
17. Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group.
Rovirosa A; Zhang Y; Chargari C; Cooper R; Bownes P; Wojcieszek P; Stankiewicz M; Hoskin P; Van der Steen-Banasik E; Segedin B; Najjari D; Pötter R; Tanderup K; Van Limbergen E; ;
Clin Transl Oncol; 2022 Feb; 24(2):254-265. PubMed ID: 34272660
[TBL] [Abstract][Full Text] [Related]
18. The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review.
Shenfield CB; Pearcey RG; Ghosh S; Dundas GS
Brachytherapy; 2009; 8(3):278-83. PubMed ID: 19230787
[TBL] [Abstract][Full Text] [Related]
19. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]